Coverage
-
December 15, 2023
Federal prosecutors urged a Pennsylvania federal judge on Friday to reject Teva Pharmaceuticals' attempt to unseal a letter explaining the government's decision to drop generic drug price-fixing charges against a New York pharmaceutical marketing executive, saying the letter isn't subject to the First Amendment's right of access.
7 other articles on this case.
View all »